Yari Ciribilli

11PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 14, 2026
p53 Isoforms as Modifiers of the p53-Dependent Responses: A Hidden Code?

Laura Bartolomei, Beatrice Pretto, Samuele Brugnara

|Dec 05, 2025
Exploring p53 isoforms: unraveling heterogeneous p53 tumor suppressor functionality in uveal melanoma.

Laura Bartolomei, Yari Ciribilli, Samuele Brugnara

|Jun 27, 2024
Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer.

Antonella Ferro, Michela Campora, Alessia Caldara

|Apr 11, 2023
ETV7 reduces inflammatory responses in breast cancer cells by repressing the TNFR1/NF-κB axis.

Erna Marija Meškytė, Laura Pezzè, Laura Bartolomei

|Jul 09, 2022
The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the <i>EGFR</i>-Mutated Lung Cancer.

Matilde Fregni, Yari Ciribilli, Joanna E Zawacka-Pankau

|Oct 23, 2021
Altered Expression of Shorter p53 Family Isoforms Can Impact Melanoma Aggressiveness.

Ana Tadijan, Francesca Precazzini, Nikolina Hanžić

Pageof 2

Frequent Collaborators

3 joint publications

Alessandra Bisio

2 joint publications

Petar Ozretić

2 joint publications

Mattia Forcato

2 joint publications

Silvio Bicciato